Skip to main content

Paratek Pharmaceuticals, Inc.

PRTKDelisted Sep 21, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001178711

Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of PRTK: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders72176+5
Shares23.3M1622.8M−511.8K (−2.2%)
Value$59.8M$41$42.6M−$17.3M (−28.8%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to PRTK in Q4 2022
InstitutionSharesValue% of portfolio
Marshall Wace, LLP43,952$82.2K0.00%
Kathmere Capital Management, LLC30,000$56.1K0.01%
Natixis29,006$54.2K0.00%
Mackenzie Financial Corp21,970$41.1K0.00%
Prudential Financial Inc20,900$39.1K0.00%
Jump Financial, LLC19,844$37.1K0.00%
Verition Fund Management LLC19,766$37.0K0.00%
Mirabella Financial Services LLP17,544$32.8K0.00%
Commonwealth Equity Services, LLC17,000$31.0K0.00%
CI Private Wealth, LLC15,550$29.1K0.00%
Arete Wealth Advisors, LLC14,050$26.3K0.00%
Two Sigma Securities, LLC12,575$23.5K0.00%
Invesco Ltd.10,550$19.7K0.00%

Sold out (8)

Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of PRTK in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
1492 Capital Management LLC501,050$1.29M
Highbridge Capital Management LLC42,154$108.0K
LMR Partners LLP17,469$45.0K
Walleye Capital LLC12,000$31.0K
Prospera Financial Services Inc11,465$29.0K
Tower Research Capital LLC (TRC)3,768$10.0K
China Universal Asset Management Co., Ltd.514$1.00K
Daiwa Securities Group Inc.86$0

Not filed for Q4 2022 yet (1)

Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PRTK in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
American Portfolios Advisors16$41